Varanoske Alyssa N, Margolis Lee M, Pasiakos Stefan M
Military Nutrition Division, U.S. Army Research Institute of Environmental Medicine, Natick, Massachusetts.
Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.
J Endocr Soc. 2020 Jul 3;4(9):bvaa090. doi: 10.1210/jendso/bvaa090. eCollection 2020 Sep 1.
Testosterone (T) administration (TA) increases serum T and fat-free mass (FFM). Although TA-mediated increases in FFM may enhance physical performance, the data are largely equivocal, which may be due to differences in study populations, the magnitude of change in serum T and FFM, or the performance metrics. This meta-analysis explored effects of TA on serum T, FFM, and performance. Associations between increases in serum T and FFM were assessed, and whether changes in serum T or FFM, study population, or the performance metrics affected performance was determined. A systematic review of double-blind randomized trials comparing TA versus placebo on serum T, FFM, and performance was performed. Data were extracted from 20 manuscripts. Effect sizes (ESs) were assessed using Hedge's g and a random effects model. Data are presented as ES (95% confidence interval). No significant correlation between changes in serum T and FFM was observed ( = .167). Greater increases in serum T, but not FFM, resulted in larger effects on performance. Larger increases in testosterone (7.26 [0.76-13.75]) and FFM (0.80 [0.20-1.41]) were observed in young males, but performance only improved in diseased (0.16 [0.05-0.28]) and older males (0.19 [0.10-0.29]). TA increased lower body (0.12 [0.07-0.18]), upper body (0.26 [0.11-0.40]), and handgrip (0.13 [0.04-0.22]) strength, lower body muscular endurance (0.38 [0.09-0.68]), and functional performance (0.20 [0.00-0.41]), but not lower body power or aerobic endurance. TA elicits increases in serum T and FFM in younger, older, and diseased males; however, the performance-enhancing effects of TA across studies were small, observed mostly in muscular strength and endurance, and only in older and diseased males.
睾酮(T)给药(TA)可提高血清T水平和去脂体重(FFM)。尽管TA介导的FFM增加可能会增强身体机能,但相关数据大多模棱两可,这可能是由于研究人群、血清T和FFM的变化幅度或机能指标存在差异所致。这项荟萃分析探讨了TA对血清T、FFM和机能的影响。评估了血清T增加与FFM增加之间的关联,并确定血清T或FFM的变化、研究人群或机能指标是否会影响机能。对比较TA与安慰剂在血清T、FFM和机能方面的双盲随机试验进行了系统评价。从20篇手稿中提取了数据。使用赫奇斯g和随机效应模型评估效应大小(ESs)。数据以ES(95%置信区间)表示。未观察到血清T变化与FFM变化之间存在显著相关性(=0.167)。血清T的更大增加而非FFM的增加,对机能产生了更大影响。在年轻男性中观察到睾酮(7.26 [0.76 - 13.75])和FFM(0.80 [0.20 - 1.41])有更大增加,但仅在患病男性(0.16 [0.05 - 0.28])和老年男性(0.19 [0.10 - 0.29])中机能有所改善。TA增加了下肢(0.12 [0.07 - 0.18])、上肢(0.26 [0.11 - 0.40])和握力(0.13 [0.04 - 0.22])强度、下肢肌肉耐力(0.38 [0.09 - 0.68])和功能表现(0.20 [0.00 - 0.41]),但未增加下肢功率或有氧耐力。TA可使年轻、老年和患病男性的血清T和FFM增加;然而,跨研究中TA的机能增强作用较小,主要在肌肉力量和耐力方面观察到,且仅在老年和患病男性中出现。